Yale Univ

Yale University is a non-profit research institution based in New Haven, Connecticut that serves as a prime recipient and prime contractor across federal research and clinical service programs, competing predominantly in full-and-open solicitations without SBA set-asides. Over ten thousand federal awards across all sources—with combined potential value exceeding $428 million and cumulative obligations of $16.25 billion—position Yale as a major federal research enterprise spanning 220 distinct customer agencies.

Yale's federal footprint concentrates heavily in research grants and service delivery. The National Institutes of Health leads customer demand by award count (1,401 awards across all NIH subdivisions), with the National Institute of Allergy and Infectious Diseases (498 awards), National Cancer Institute (432 awards), and National Heart, Lung, and Blood Institute (396 awards) anchoring life-sciences research activity. However, the Department of Veterans Affairs Veterans Integrated Service Network 1 dominates by potential value, anchoring $124.8 million across 274 awards—primarily histology testing, biomedical services, programming and statistical analysis, and veterinary clinical services delivered at Yale facilities in New Haven, West Haven, and Hamden, Connecticut. The Veterans Affairs relationship reflects Yale's established role as a biomedical services provider to the federal healthcare system, with multiple indefinite-delivery contracts supporting task-order placement through December 2029.

Recent activity demonstrates sustained research intensity. Yale averaged 584 to 844 awards annually from 2023 to 2025, though 2026 data in the source represent only the first five months. Combined obligated dollars ($16.25 billion) far exceed combined potential value, indicating that Yale frequently receives extensions and modifications to existing awards rather than purely incremental growth. Approximately 926 awards face completion within the next twenty-four months, representing $14.5 million in recompete exposure across service contracts and research grants.

Yale's prime contractor posture (87% of awards) contrasts with its substantial role as a sub-recipient on externally funded grants. The vendor award portfolio identifies over 1,260 sub-award positions where Yale delivers targeted research services—spatial genomics, immunological analysis, computational modeling, clinical trial support—under prime leadership from Johns Hopkins, Columbia, University of Pennsylvania, and others. Service Contract Inventory data show minimal SCI-reportable invoiced activity ($980 thousand across FY2022–FY2024), reflecting that Yale's federal revenue derives predominantly from research grants and clinical service contracts outside the SCI threshold rather than from traditional time-and-materials service agreements. Median government-paid rates on SCI records run approximately $72.69 per hour, with senior labor priced through $129 per hour, typical of academic research labor.

Yale's grant portfolio emphasizes fundamental biomedical investigation and clinical research. Recent awards include $3.3 million from the National Institute of Neurological Disorders and Stroke for neural repair in spinal cord injury using Nogo receptor blockade (cooperative agreement through November 2030); $2.34 million from NIAID for celiac disease pathogenesis and activity assessment employing pan-expansion microscopy and spatial transcriptomics across four collaborating medical centers; $1.68 million from the National Heart, Lung, and Blood Institute for vascular development mechanisms in brain Circle of Willis using zebrafish and iPSC organoid models; and $1.41 million from NIAID for residual malaria transmission mechanisms in the Peruvian Amazon, with sub-awards to Harvard and Universidad Peruana Cayetano Heredia managing data and field operations. Contract work with Veterans Affairs includes single-award indefinite-delivery vehicles for veterinary clinical services ($1.5 million ceiling through December 2029) and prior-year task orders for biomedical services, histology testing, and programming and statistical analysis supporting VA research and clinical operations.

Yale operates as a parent entity with no separately named subsidiaries carrying distinct capability framing in the source. The university's research infrastructure—including specialized facilities for flow cytometry, brain PET imaging, genomics analysis, and preclinical animal models—enables broad federal procurement across basic science, translational research, and clinical service delivery. National Science Foundation awards (1,009 by count) fund physics, computer science, mathematics, and environmental biology research, while NASA Shared Services Center awards (248 by count, $32.3 million combined potential value) support space science and engineering projects typically managed through Yale's engineering and physics departments.

Activity trajectory shows continued federal research investment. Year-over-year awards ranged from 508 to 844 from 2022 through 2025, with 2022–2023 representing baseline post-pandemic stabilization and 2024 representing significant growth. The recompete cliff of 926 awards with completion inside twenty-four months suggests sustained renewal demand across both grants and service contracts, with particular concentration among NIH institutes and Veterans Affairs programs. Yale's established relationships with federal agencies, its peer-review success across competitive research solicitations, and its capacity to execute complex multi-site clinical trials and biomedical investigations position it for continued large-scale federal engagement, though competitive pressures from peer research universities and evolving federal research priorities will influence future award volumes and composition.